LONDON - A malaria vaccine has become the first to be recommended for widespread use across Africa.
Health experts hope the jab, developed by the Brentford-based pharmaceutical company GlaxoSmithKline, will significantly reduce rates of the disease that claims the lives of more than a quarter of a million African children under the age of five each year.
Dr Tedros Adhanom Ghebreyesus, the World Health Organization director-general, described the approval as “a historic moment”.
The World Health Organization (WHO) is recommending widespread use of the world’s first malaria vaccine, in what the UN health agency’s chief described on Wednesday as “an historic day” for the decades-long battle against the deadly disease.
